Physician
Mercy Hospitals East Communities
Mercy Hospitals East Communities was paid $25.34M by Medicaid between Jan 2018 and Dec 2024, across 106 billing codes. Its largest line is 99285, emergency room visit (most serious) — 21% of everything it billed.
33Billing provider infoMERCY HOSPITALS EAST COMMUNITIES
WASHINGTON, MO 63090
WASHINGTON, MO 63090
33aNPI1285664177assigned 07/04/2006
33bProvider typeEmergency Medicine Physician
28Total paid$25.34M
24GClaims224,478
24DCodes billed106
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Missouri
Rank by total paid#1 of 571
Median peer was paid$14K
This provider vs. median1,794×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,775 | $6.75M | |
| 2019 | 26,883 | $4.25M | |
| 2020 | 24,405 | $2.14M | |
| 2021 | 30,696 | $1.35M | |
| 2022 | 35,734 | $2.99M | |
| 2023 | 45,814 | $4.42M | |
| 2024incomplete | 32,171 | $3.45M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21% | 28,480 | 21,185 | $5.30M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 32,469 | 24,997 | $3.97M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 26,602 | 21,185 | $3.86M |
| Y7506 | 11% | 19,458 | 17,030 | $2.91M | |
| X4011 | State-specific procedure code | 10% | 13,000 | 12,299 | $2.56M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.2% | 28,522 | 25,586 | $1.56M |
| 80053 | Comprehensive metabolic panel | 4.0% | 22,336 | 20,207 | $1.01M |
| X4006 | 3.0% | 1,638 | 1,367 | $756K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 6,783 | 6,454 | $673K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 5,192 | 4,978 | $294K |
| 59025 | Fetal non-stress test | 1.1% | 2,133 | 992 | $274K |
| 83690 | <1% | 4,073 | 3,897 | $186K |
94 more codes
| 81001 | <1% | 3,712 | $167K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 384 | $144K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,970 | $139K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,205 | $122K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 436 | $102K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 925 | $94K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,126 | $91K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,498 | $88K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 433 | $80K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,425 | $65K |
| X4003 | <1% | 951 | $65K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,269 | $61K |
| 83735 | <1% | 650 | $49K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 387 | $46K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 103 | $45K |
| 84484 | <1% | 1,122 | $36K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 672 | $36K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 767 | $32K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 196 | $30K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 89 | $29K |
| 73630 | <1% | 787 | $28K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 370 | $24K |
| 64483 | <1% | 99 | $24K | |
| 86803 | <1% | 299 | $23K | |
| 62323 | <1% | 66 | $21K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 101 | $20K |
| 94761 | <1% | 171 | $20K | |
| 81003 | <1% | 395 | $19K | |
| 86140 | <1% | 330 | $18K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 283 | $18K |
| G0378 | Hospital observation service, per hour | <1% | 17 | $15K |
| 87081 | <1% | 162 | $15K | |
| 81025 | <1% | 1,376 | $15K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 13 | $14K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 45 | $12K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,625 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 260 | $11K |
| 76801 | <1% | 95 | $10K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $10K |
| 71250 | <1% | 218 | $9K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 86 | $9K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 30 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 165 | $8K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 49 | $7K |
| 93271 | <1% | 131 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 260 | $6K |
| 80081 | <1% | 50 | $6K | |
| J3490 | Unclassified drugs | <1% | 3,386 | $6K |
| Y7507 | <1% | 101 | $6K | |
| 87807 | <1% | 13 | $5K | |
| 94726 | <1% | 65 | $5K | |
| 87070 | <1% | 239 | $5K | |
| 85610 | <1% | 61 | $5K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $4K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 41 | $4K |
| 80061 | Lipid panel | <1% | 304 | $4K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 12 | $3K |
| 87631 | <1% | 12 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 140 | $3K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 13 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 42 | $3K |
| 87430 | <1% | 199 | $2K | |
| 95806 | <1% | 25 | $2K | |
| 87653 | <1% | 12 | $2K | |
| 94618 | <1% | 51 | $2K | |
| 94729 | <1% | 61 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 29 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 15 | $1K |
| 87428 | <1% | 32 | $882.64 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $841.38 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 16 | $706.64 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 12 | $697.91 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 46 | $492.06 |
| 82950 | <1% | 25 | $399.30 | |
| 0240U | <1% | 27 | $285.26 | |
| 83970 | <1% | 12 | $261.13 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $165.76 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $140.35 |
| 81002 | <1% | 38 | $102.61 | |
| 82947 | <1% | 46 | $92.88 | |
| 84439 | <1% | 17 | $86.98 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 48 | $84.21 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 48 | $84.21 |
| 80069 | <1% | 13 | $47.35 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 108 | $36.80 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 12 | $21.28 |
| 82962 | <1% | 13 | $13.10 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 28 | $1.35 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 58 | $0.42 |
| J2704 | Injection, propofol, 10 mg | 0% | 44 | $0.00 |
| A9270 | Non-covered item or service | 0% | 14 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 403 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 15 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHORN, MARK (EXECUTIVE DIRECTOR FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Mercy Hospital Lincoln | Troy, MO | $10.53M |
| Mercy Hospitals East Communities | Washington, MO | $3.17M |
| Mercy Hospital Lincoln | Troy, MO | $930K |
| Mercy Hospital Lincoln | Troy, MO | $786K |
| Mercy Hospital Lincoln | Elsberry, MO | $183K |
| Mercy Hospital Lincoln | Winfield, MO | $135K |
| Mercy Hospital Lincoln | Troy, MO | $88K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.